AFib (HR erratic, up to 180 bpm); minimal soreness at injection site; Bumps, rash-like, 50 bumps in total, mostly from very top of thighs up, but some on rt knee. Most on rt side, but not all. A few bumps at first, and then more.; Vaginal Yeast Infection; LDL increased; Diarrhea; Calcium decreased; Creatinine increased; Glucose increased; Albumin decreased; Sodium decreased; BUN increased; Stye in Rt eye; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Mar2022 as dose 4 (booster), single (Lot number: FK9894), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Chest radiograph", start date: 08Apr2016, stop date: 08Apr2016, notes: CLINICAL INDICATION: Chest Pain.; "Breast implant" (unspecified if ongoing); "Shortness of breath" (unspecified if ongoing); "GI pains" (unspecified if ongoing); "Sigmoid colectomy", start date: 22Jun2022, stop date: 22Jun2022, notes: Cancer ruled out.; "TMJ", start date: Oct1980 (unspecified if ongoing); "TMJ arthroplasty", start date: 03Apr1985 (unspecified if ongoing); "hysterectomy", start date: 14Nov1989 (unspecified if ongoing), notes: ovaries not removed; "sentinel node dissection", start date: 07Mar2016 (unspecified if ongoing), notes: port placement (though updated diagnosis changed and no chemo needed); "bilateral mastectomy", start date: 15Apr2016 (unspecified if ongoing); "swap out expander for implants AND port removal", start date: 23Sep2016 (unspecified if ongoing); "bunionectomy", start date: 25Jan2018 (unspecified if ongoing); "arthritis in Rt knee", start date: Dec2018 (unspecified if ongoing), notes: some Hymovis injections and Zilretta injections every 3 months; "flushing" (unspecified if ongoing); "Headache" (unspecified if ongoing); "Insomnia" (unspecified if ongoing); "clogged eye oil glands" (unspecified if ongoing); "bone health" (unspecified if ongoing); "hair health" (unspecified if ongoing); "Joints" (unspecified if ongoing); "breast cancer", start date: 2016 (unspecified if ongoing), notes: diagnosed early 2016; "Hernia" (unspecified if ongoing), notes: the cause of many of the more minor GI pains that resolved w/o antibiotics; "nail health" (unspecified if ongoing); "COVID-19" (unspecified if ongoing); "sentinel node dissection" (unspecified if ongoing); "Robotic surgery" (unspecified if ongoing), notes: undetected hernia (1.5cm x 3 cm), pocket was cleaned out and the tear repaired; "latex (blistering with prolonged contact)" (unspecified if ongoing); "Diverticulitis", start date: 28Apr2017 (unspecified if ongoing); "Subsequent bouts", start date: 15Aug2018 (unspecified if ongoing), notes: (possibly exacerbated by 08Aug2018 Shingrix vaccination),; "bilateral mastectomy", start date: 15Apr2016 (unspecified if ongoing), notes: (right side at my option); "swap out expander for implants AND port removal", start date: 23Sep2016 (unspecified if ongoing); "Chest Pain" (unspecified if ongoing). Concomitant medication(s) included: B12 [CYANOCOBALAMIN], start date: 2017, stop date: 17Jul2022; FISH OIL taken for acne, start date: 01Nov2018, stop date: 17Jul2022; CALCIUM CITRATE taken for bone disorder, start date: Apr2016, stop date: 17Jun2022; D3 taken for bone disorder, start date: 2021, stop date: 17Jul2022; BIOTIN taken for hair disorder, nail disorder, start date: 2017, stop date: 17Jul2022; BIOFLEX CHONDROITIN taken for arthropathy, start date: 01Feb2020, stop date: 17Jul2022; MIDAZOLAM, start date: 22Jun2022 at 07:34; LIDOCAINE HCL, start date: 22Jun2022 at 07:44; DIPRIVAN, start date: 22Jun2022 at 07:44; EXPAREL, start date: 22Jun2022 at 07:59; NAROPIN [ROPIVACAINE], start date: 22Jun2022 at 07:59; DECADRON [DEXAMETHASONE], start date: 22Jun2022 at 08:17; SUBLIMAZE [FENTANYL], start date: 22Jun2022 at 09:10; BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE], start date: 22Jun2022 at 09:18; INDIGO CARMINE, start date: 22Jun2022 at 10:14; ROCURONIUM, start date: 22Jun2022 at 11:27; ZOFRAN [ONDANSETRON], start date: 22Jun2022 at 12:04; EPHEDRINE, start date: 22Jun2022 at 12:09; BRIDION, start date: 22Jun2022 at 12:16; INVANZ. Past drug history included: Danocrine, reaction(s): "significant hives"; Depo-medrol, reaction(s): "severe headache"; Depo-medrol, reaction(s): "insomnia"; Depo-medrol, reaction(s): "several days of hot flushing - red faced"; Arimidex (anastrozole), start date: 2016, stop date: 28Apr2017, reaction(s): "Breast cancer", notes: Cases prior to 16Apr2020 would not resolve until I discontinued Arimidex (anastrozole) that I was taken subsequent to ER+, PR+, HER2- breast cancer diagnosed early 2016.; Flagyl, start date: 17Mar2022, notes: 500 mg, Preop, at 1, 2, and 11 pm; Bactrim, start date: 17Mar2022, notes: 800-160 mg; Zilretta injections for TX for arthritis in Rt knee, notes: every 3 months; Suprep bowel prep, start date: 24May2022, stop date: 24May2022, notes: Prior to colonoscopy. Only half dose needed due to having been on liquid diet.; Miralax, start date: 21Jun2022, stop date: 21Jun2022, notes: Miralax (238 mg) taken day before colectomy. Vaccination history included: coviD-19 vaccine moderna (DOSE 1, SINGLE; Lot number: 029L20A, Dose: 0.5 ml; Site of administration: Right Arm, Time: about 10 am), administration date: 27Jan2021, for COVID-19 immunization, reaction(s): "sore injection site", "slight tenderness at injection site", "red injection site", "swollen arm (injection site reaction)", "sore injection site", "red injection site", "swollen arm (injection site reaction)"; coviD-19 vaccine moderna (DOSE 2, SINGLE; Lot number: 023M20A, Dose: 0.5 ml; Site of administration: Right thigh), administration date: 24Feb2021, for COVID-19 immunization, reaction(s): "sore thigh", "red thigh", "swollen thigh", "Fever", "Chills"; shingrix vaccine (possibly exacerbated by 08Aug2018, Shingrix vaccination), 22Jul2019, 23Mar2021, 23Dec2021, 17Mar2022), administration date: 08Aug2018, reaction(s): "Diverticulitis"; hymovis shots, administration date: 18Mar2021, for arthritis in Rt knee. The following information was reported: HORDEOLUM (non-serious) with onset 09May2022, outcome "recovered" (21May2022), described as "Stye in Rt eye"; BLOOD ALBUMIN DECREASED (non-serious) with onset 11Jun2022, outcome "unknown", described as "Albumin decreased"; BLOOD UREA INCREASED (non-serious) with onset 11Jun2022, outcome "unknown", described as "BUN increased"; BLOOD SODIUM DECREASED (non-serious) with onset 11Jun2022, outcome "unknown", described as "Sodium decreased"; BLOOD CALCIUM DECREASED (non-serious) with onset 23Jun2022, outcome "unknown", described as "Calcium decreased"; BLOOD CREATININE INCREASED (non-serious) with onset 23Jun2022, outcome "unknown", described as "Creatinine increased"; BLOOD GLUCOSE INCREASED (non-serious) with onset 23Jun2022, outcome "unknown", described as "Glucose increased"; ATRIAL FIBRILLATION (hospitalization, medically significant) with onset 26Jun2022, outcome "recovered", described as "AFib (HR erratic, up to 180 bpm)"; DIARRHOEA (non-serious) with onset 26Jun2022, outcome "not recovered", described as "Diarrhea"; LOW DENSITY LIPOPROTEIN INCREASED (non-serious) with onset 26Jun2022, outcome "unknown", described as "LDL increased"; VULVOVAGINAL MYCOTIC INFECTION (non-serious) with onset 29Jun2022, outcome "recovered" (Jun2022), described as "Vaginal Yeast Infection"; RASH (non-serious) with onset 10Jul2022, outcome "recovering", described as "Bumps, rash-like, 50 bumps in total, mostly from very top of thighs up, but some on rt knee. Most on rt side, but not all. A few bumps at first, and then more."; INJECTION SITE PAIN (non-serious), outcome "unknown", described as "minimal soreness at injection site". The patient was hospitalized for atrial fibrillation (start date: 26Jun2022, discharge date: 27Jun2022, hospitalization duration: 2 day(s)). The event "stye in rt eye" required physician office visit. The event "afib (hr erratic, up to 180 bpm)" required emergency room visit. The patient underwent the following laboratory tests and procedures: Alanine aminotransferase: (11Jun2022) 28 Units/L, notes: Standard Range: Standard Range less than 64 Units/L; Alanine aminotransferase (normal high range 64): (21Sep2021) 28, notes: Units/L; Albumin globulin ratio (1.0-2.4): (21Sep2021) 0.8, notes: Flag L; (11Jun2022) 0.8, notes: Standard Range: Standard Range 1.0 - 2.4 Flag: Flag L; Angiogram: (unspecified date) Unknown results; Anion gap (7-19): (21Sep2021) 13 mmol/L; (23Jun2022) 13 mmol/L; Anion gap (10-20): (11Jun2022) 13 mmol/L, notes: Standard Range: Standard Range 10 - 20 mmol/L; Basophil count (0.0-0.3): (unspecified date) 0.0 K/mcL, notes: Standard Range: Standard Range 0.0 - 0.3 K/mcL; Basophil count: (unspecified date) 0 %, notes: Standard Range: Standard Range %; Blood albumin (3.6-5.1): (21Sep2021) 3.3 g/dl, notes: Flag L; (11Jun2022) 3.3 g/dl, notes: Standard Range: Standard Range 3.6 - 5.1 g/dL; Blood alkaline phosphatase (45-117): (21Sep2021) 62, notes: Units/L; (11Jun2022) 62 Units/L, notes: Standard Range: Standard Range 45 - 117 Units/L; Blood bilirubin (0.2-1.0): (21Sep2021) 0.5 mg/dl; (11Jun2022) 0.5 mg/dl, notes: Standard Range: Standard Range 0.2 - 1.0 mg/dL; Blood calcium (8.4-10.2): (21Sep2021) 8.9 mg/dl; (11Jun2022) 8.9 mg/dl, notes: Standard Range: Standard Range 8.4 - 10.2 mg/dL; (23Jun2022) 8.0 mg/dl, notes: Flag L; Blood chloride (98-107): (11Jun2022) 107 mmol/L, notes: Standard Range: Standard Range 98 - 107 mmol/L; Blood chloride (97-110): (21Sep2021) 107 mmol/L; (23Jun2022) 105 mmol/L; Blood cholesterol: (26Jun2022) 199 mg/dl, notes: Standard Range: Standard Range less than 00 mg/dL. Patient is to continue watching diet and exercise; Blood cholesterol (normal high range 00): (unspecified date) 199 mg/dl; (22Oct2021) 199 mg/dl; Blood creatinine (0.51-0.95): (11Jun2022) 0.65 mg/dl, notes: Standard Range: Standard Range 0.51 - 0.95 mg/dL; Blood creatinine (0.51-0.95): (21Sep2021) 0.65 mmol/L; (23Jun2022) 1.07 mmol/L, notes: Flag H; Blood glucose: (11Jun2022) normal at 88 Kidney; Blood glucose (65-99): (11Jun2022) 88 mg/dl, notes: Standard Range: Standard Range 65 - 99 mg/dL; Blood glucose (70-99): (21Sep2021) 88 mmol/L; (23Jun2022) 154 mmol/L, notes: Flag H; Blood potassium (3.4-5.1): (21Sep2021) 4.3 mmol/L; (11Jun2022) 4.3 mmol/L, notes: Standard Range: Standard Range 3.4 - 5.1 mmol/L; (23Jun2022) 4.4 mmol/L; Blood pressure measurement: (11Jun2022) 99/59; Blood sodium (135-145): (21Sep2021) 144 mmol/L; (11Jun2022) 114 mmol/L, notes: Fasting Status: Sodium Standard Range: Standard Range 135 - 145 mmol/L; (23Jun2022) 138 mmol/L; Blood triglycerides: (unspecified date) 66; Blood triglycerides: (26Jun2022) normal at 66, notes: Standard Range: Standard Range less than 150 mg/dL. Patient is to continue watching diet and exercise; Blood triglycerides (normal high range 150): (22Oct2021) 66 mg/dl; Blood urea (6-20): (11Jun2022) 17 mg/dl, notes: Standard Range: Standard Range 6 - 20 mg/Dl; Blood urea (6-20): (21Sep2021) 17 mmol/L; (23Jun2022) 11 mmol/L; Blood urea: (11Jun2022) 26, notes: Standard Range: Standard Range 7 - 25 Flag: Flag H; Carbon dioxide (21-32): (21Sep2021) 28 mmol/L; (11Jun2022) 28 mmol/L, notes: Standard Range: Standard Range 21 - 32 mmol/L; (23Jun2022) 24 mmol/L; Chest X-ray: (unspecified date) Negative; (unspecified date) There is no component information for this result., notes: No suspicious pulmonary infiltrates. Blunting of the right costophrenic angle No pneumothorax The cardio media tinal ilhouette i unremarkable; Computerised tomogram thorax: (21Sep2021) No pulmonary embolus, notes: Small right and trace left pleural effusion with mild atelectasis at the lung bases; Echocardiogram: (unspecified date) unremarkable, notes: Comments from the Doctor's Office: Echocardiogram is unremarkable. Patient is cleared for surgery. Impression: Tran thoracic Echocardiogram (TTE); (unspecified date) Unknown results; (11Jun2022) 2.56; Ejection fraction: (unspecified date) 70 %; (11Jun2022) 70 %; Electrocardiogram: (unspecified date) Abnormal; (25Mar2021) sinus rhythm, notes: with occasional supraventricular premature complexes possible left atrial enlargement incomplete right bundle branch block borderline ecg unconfirmed report confirmed by, (15570) on 29Mar2021 9:23:38 am; (26Jun2022) atrial fibrillation, notes: with rapid ventricular response nonspecific st & t-wave abnormality abnormal rhythm ecg unconfirmed report confirmed by (5049) on 26Jul2022 10:05:34 am; (26Jun2022) atrial fibrillation septal myocardial infarction, notes: of indeterminate age abnormal ecg unconfirmed report confirmed by (5049) on 26Jul2022 10 :05 :37 am; (26Jun2022) sinus rhythm possible left atrial enlargement, notes: [-0.1mv p wave in v1/v2] septal myocardial infarction [40+ m q wave in v1/v2], of indeterminate age abnormal ecg unconfirmed report confirmed by medical on 26Jul2022 10:05:41 am; (25Mar2021) 78; (26Jun2022) 159; (26Jun2022) 85; (26Jun2022) 66; Electrocardiogram QT interval: (25Mar2021) 369; (26Jun2022) 182; (26Jun2022) 318; (26Jun2022) 337; (25Mar2021) 402; (26Jun2022) 271; (26Jun2022) 360; (26Jun2022) 351; Eosinophil count (0.0-0.5): (unspecified date) 0.0 K/mcL, notes: Standard Range: Standard Range 0.0 - 0.5 K/mcL; Eosinophil count: (unspecified date) 0 %, notes: Standard Range: Standard Range %; Full blood count: (unspecified date) Normal; (11Jun2022) normal; Globulin (2.0-4.0): (21Sep2021) 4.1, notes: Flag H; Globulin (2.0-4.0): (11Jun2022) 4.1 g/dl, notes: Standard Range: Standard Range 2.0 - 4.0 g/Dl Flag: Flag H; Glomerular filtration rate: (11Jun2022) 89, notes: Standard Range: Standard Range greater than equals to 60; Glomerular filtration rate (normal low range 60): (21Sep2021) 89, notes: Standard Range greater than equals to 60; (23Jun2022) 55, notes: Standard Range greater than equals to 60 Flag L; Glycosylated haemoglobin: (unspecified date) 5.5 %; (11Jun2022) 5.5 %, notes: Normal. No diabetes seen; Granulocyte count (0.0-0.2): (unspecified date) 0.1 K/mcL, notes: Standard Range: Standard Range 0.0 - 0.2 K/mcL; Granulocyte count: (unspecified date) 1 %, notes: Standard Range: Standard Range %; Haematocrit: (unspecified date) 36.4 %, notes: Standard Range 36 0 46 5 %; Haemoglobin: (unspecified date) 12.0 g/dl, notes: Standard Range: Standard Range 1 0 15 5 g/dL; High density lipoprotein: (unspecified date) 61, notes: Good; High density lipoprotein: (26Jun2022) very good at 61, notes: Standard Range: Standard Range greater than OR 50 mg/dL. Patient is to continue watching diet and exercise; High density lipoprotein (normal low range 50): (22Oct2021) 61 mg/dl; Annulus: (unspecified date) Normal; (unspecified date) Normal; (11Jun2022) 3.00; (11Jun2022) 0.80; (11Jun2022) 6.00; (11Jun2022) 1.24; (unspecified date) 88, notes: Blood sugar is normal at 88 Kidney and liver function is normal; BUN/ Creatinine Ratio (7-25): (21Sep2021) 26; (23Jun2022) 10; (26Jun2022) Unknown results, notes: After intravenous administration of contrast, there is adequate opacification of the pulmonary arteries. No suspicious filling defects to suggest presence of a pulmonary embolus No evidence of right heart strain. The heart size within normal limits. No pericardial effusion. No thoracic aortic aneurysm. No mediastinal or hilar lymphadenopathy; (27Jun2022) Unknown results, notes: No suspicious pulmonary infiltrates. Blunting of the right costophrenic angle No pneumothorax The cardiomediastinal silhouette is unremarkable; CHOL/HDLC RATIO (normal high range 5): (22Oct2021) 3.3, notes: calc; (11Jun2022) 1.2; (unspecified date) Normal; (11Jun2022) 227; (11Jun2022) 17.44; estimated central venous pressure: (unspecified date) 3 mmHg; (unspecified date) 17 mmHg; (unspecified date) Normal; (unspecified date) Normal; (unspecified date) Normal; (11Jun2022) 2.26; (unspecified date) Normal; (11Jun2022) 3.23; (unspecified date) 1.02; (11Jun2022) 24.8; (unspecified date) normal; (unspecified date) 1 mmHg; (unspecified date) 3 mmHg; (unspecified date) Normal; (11Jun2022) 10.9; (11Jun2022) 9.03; (11Jun2022) 7.1650055371; NON HDL CHOLESTEROL (normal high range 130): (22Oct2021) 138 mg/dl, notes: calc; (25Mar2021) 81; (26Jun2022) 75; (unspecified date) 6 mmHg; (unspecified date) 6 mmHg; (unspecified date) Normal; (27Jun2022) 148, notes: Standard Range BPM; (25Mar2021) 159; (26Jun2022) 165; (11Jun2022) 1.26; (25Mar2021) 114; (26Jun2022) 100; (26Jun2022) 92; (26Jun2022) 89; (25Mar2021) 71; (26Jun2022) 60; (26Jun2022) 52; (26Jun2022) 49; (unspecified date) 0.97; respirophasicdiameter (normal high range 50): (unspecified date) normal; (unspecified date) mildly dilated; (unspecified date) Normal; (unspecified date) 17 mmHg; (22Jun2022) Unknown results; (unspecified date) Normal; (25Mar2021) 69; (26Jun2022) 0; (26Jun2022) 43; (26Jun2022) 59; (unspecified date) Normal; (11Jun2022) 17.4; (unspecified date) 3.3cm^2; (unspecified date) 1.96cm^2/m^2; (unspecified date) Normal; Liver function test: (11Jun2022) 18 Units/L, notes: Standard Range: Standard Range less than equals 37 Units/L; Liver function test (normal high range 37): (21Sep2021) 18, notes: Units/L; (11Jun2022) normal; Low density lipoprotein: (unspecified date) 122; Low density lipoprotein: (26Jun2022) slightly elevated at 122, notes: Standard Range: Standard Range mg/dL (calc). Patient is to continue watching diet and exercise; (22Oct2021) 122 mg/dl, notes: Flag H; Lymphocyte count (1.0-4.0): (unspecified date) 1.9 K/mcL, notes: Standard Range: Standard Range 1.0 - 4.0 K/mcL; Lymphocyte count: (unspecified date) 14 %, notes: Standard Range: Standard Range %; Mean cell haemoglobin concentration (30-36.5): (unspecified date) 33.0 g/dl, notes: Standard Range: Standard Range 30 36.5 g/dL; Mean cell volume (78.0-100.0): (unspecified date) 100.6 fl, notes: Standard Range: Standard Range 78.0 100.0 fl Flag: Flag L; Monocyte count (0.3-0.9): (unspecified date) 1.1 K/mcL, notes: Standard Range: Standard Range 0.3 - 0.9 K/mcL Flag: Flag H; Monocyte count: (unspecified date) 8 %, notes: Standard Range: Standard Range %; Neutrophil count (1.8-7.7): (unspecified date) 10.9 K/mcL, notes: Standard Range: Standard Range 1.8 - 7.7 K/mcL Flag: Flag H; Neutrophil count: (unspecified date) 77 %, notes: Standard Range: Standard Range %; Non-high-density lipoprotein cholesterol: (26Jun2022) 138 mg/dl, notes: Standard Range: Standard Range less than 130 mg/dL (calc); Platelet function test (140-450): (unspecified date) 209 K/mcL, notes: Standard Range: Standard Range 140 - 450 K/mcL; Protein total (6.4-8.2): (21Sep2021) 7.4; Protein total (6.4-8.2): (11Jun2022) 7.4 g/dl, notes: Standard Range: Standard Range 6.4 - 8.2 g/dL; Red blood cell count: (unspecified date) 0 /100 WBC, notes: Standard Range: Standard Range less than equals to 0 /100 WBC; (unspecified date) 3.62 mil/mcL, notes: Standard Range: Standard Range 4 00 5 0 mil/mcL Flag: Flag L; Red cell distribution width (11.0-15.0): (unspecified date) 12.6 %, notes: Standard Range: Standard Range 11.0 15.0 %; Red cell distribution width (30 0-50 0): (unspecified date) 46.5 fL, notes: Standard Range: Standard Range 39 0 50 0 fL; SARS-CoV-2 test: (unspecified date) Unknown results; (06Jan2022) Negative; Scan: (11Jun2022) 9.03, notes: Component: MV E Tissue Vel Med; (11Jun2022) 10.9, notes: Component: MV E Tissue Vel Lat; (11Jun2022) 1.26, notes: Component: PV Peak Velocity; (11Jun2022) 17.4, notes: Component: Tricuspid valve annular peak velocity; (11Jun2022) 17.44, notes: Component: Est Right Vent Systolic Pressure by Tricuspid Regurgitation Jet; (11Jun2022) 24.8, notes: Component: LVOT VTI; (11Jun2022) 1.2, notes: Component: DOP Calc LVOT Peak Vel; (11Jun2022) 3.23, notes: Component: Left Ventricular Internal Dimension in Diastole; (11Jun2022) 2.26, notes: Component: Left Internal Dimension in Systole; (11Jun2022) 2.56, notes: Component: Tricuspid Annular Plane Systolic Excursion; Thyroid function test: (unspecified date) Normal; (11Jun2022) normal; Total cholesterol/HDL ratio: (26Jun2022) 3.3 (calc), notes: Standard Range: Standard Range less than 5 0 (calc); White blood cell count: (unspecified date) 14.0 K/mcL, notes: Standard Range: Standard Range 4 11 0 K/mcL Flag: Flag H. Therapeutic measures were taken as a result of diarrhoea, vulvovaginal mycotic infection, rash, hordeolum. Per clinical course, Patient happened to be talking to a MODERNA employee about possible enrollment in a clinical trial for her husband when she happened to mention a drug reaction that she was having a rash. The rash was suspected to be related to a drug (including probiotics) taken in the last year (per the dermatologist); the culprit had not yet been identified, but the current best guess is probiotics: 4 different probiotic challenges have resulted in a rash. Each time, the rash cleared over then subsequent 1-3 weeks. However, that conversation required her to submit an AE report, and Moderna followed up with me. Because she did not particularly think that the crash was caused by the vaccine, please do not bother the medical professionals who have treated her. You do not have my permission to contact my providers without contacting me first. I do not want to waste their time. It was easier to type the information than to fill out the form. Allergic to Danocrin (significant hives), depo-medrol (severe headache, insomnia, several days of hot flushing-red faced), latex (blistering with prolonged contact), and possible other drug (rash that is currently presumed to be due to new probiotics introduced after multiple rounds of antibiotics in the spring, followed by colon surgery for diverticulitis in June. COVID history: On 30Dec2021, she was symptomatic (mild cold symptoms, no loss of taste or smell, no fever), had possibly been exposed to COVID, and so she was tested. The results were not reported for about 2 weeks (and later it was determined that the testing site was somewhat suspect.) With no results available, on 06Jan2022 she tested negative at # (facility name withheld). About 2 weeks later, the first test was reported out as Positive. Given the bad reputation of the first site, it is Unknown whether or not she has had COVID 19. No acute illnesses when vaccinated. Chronic or long-standing health conditions. Diverticulitis started 28Apr2017. Subsequent bouts 15Aug2018 (possibly exacerbated by 08Aug2018. Shingrix vaccination), 22Jul2019, 23Mar2021, 23Dec2021, 17Mar2022. Cases prior to 16Apr2020 would not resolve until I discontinued Arimidex (anastrozole) that she was taken subsequent to ER+, PR+, HER2- breast cancer diagnosed early 2016. Arimidex was stopped on 28Apr2017 due to onset of substantial side effects (hot flashes, feeling awful); my extremely favorable cancer prognosis did not justify continuing the Arimidex and treating the symptoms that drug caused. In addition to treated diverticulitis cases, she had a large number of untreated) GI pains, the frequency and severity of which increased over time. After the 17Mar2022 case, she saw a surgeon, who recommended surgery, but a colonoscopy was to be performed first to rule out cancer (it was ruled out). She was on a 7-day course of flagyl 500 mg and Bactrim 800-160 mg starting 17Mar2022, then an 11-day course of Flagyl and a 7-day course of Bactrim starting 10Jun22. The day before surgery (ie, on 21Jun2022) she had flagyl: 500 mg: Preop, at 1, 2, and 11 pm neomycin: 1 g (2 tabs): Preop, at 1, 2, and 11 pm. Then in surgery she had more antibiotics. Sigmoid colectomy performed 22Jun2022. Cancer ruled out. At the time of (robotic) surgery, a previously undetected hernia (1.5cm x 3 cm) was found; the pocket was cleaned out and the tear repaired. This hernia was almost surely the cause of many of the more minor GI pains that resolved w/o antibiotics. Treated with Tylenol and very little morphine in the hospital (she did not get much relieve from the morphine because she did not think she could push the pump often and she did not know the dose in the bag was so low. But she did not hurt terribly anyhow. Treated with Tylenol and 2 days of Oxycodone at home. Other significant long-standing medical history includes: TMJ (started Oct1980) and TMJ arthroplasty (03Apr1985). No recent changes 14Nov1989 hysterectomy (ovaries not removed) 07Mar2016 sentinel node dissection, port placement (though updated diagnosis changed and no chemo TX needed) 15Apr2016 bilateral mastectomy (right side at my option), 23Sep2016 swap out expander for implants AND port removal, 25Jan2018 bunionectomy, Dec2018 ff: for arthritis in Rt knee: some Hymovis injections and Zilretta injections every 3 months. The knee gets better, then worse, then better, then worse with injection. Recent injections: 21Jan2021, 26Aug2021, 02Dec2021, 09Mar2022, 09Jun2022; 15Sep2022. On 11May2021 had Depo- Medrol instead of Zilretta with reactions of headache, insomnia, flushing (like sunburn) - and it not only didnot help my knee, but it also made it worse for 3 months. (This is another AE - AE #17 below - but not due to moderna. flushing resolved in 4 days, headache in 2-3 days, insomnia in 1 days. pain in knee was not improved) Hymovis shots 11Mar2021 and 18Mar2021. Suprep Bowel Prep taken 24May2022, prior to colonscopy. Only half dose needed due to having been on liquid diet and Miralax for a week prior to procedure. Miralax (238 mg) taken 21Jun2022 day before colectomy. Primary on 14Jul2022 am. Because Eliquis was suspected, went to cardiologist 14Jul2022 pm. Eliquis to Xarelto. She suspect Eliquis was unfairly blamed for rash. Went to Dermatologist 18Jul2022. Biopsy report was suspected bug bite, contact dermatitis, drug reaction, or bullous pemphigoid. Overall rash was not consistent with bite or contact dermatitis. Bullous pemphigoid was later ruled out by biopsy. Medications Given for 22Jun2022 surgery: MIDAZolam (VERSED) Last given 22Jun2022 7:34 AM, lidocaine HCl Last given 22Jun2022 7:44 AM, propofol (DIPRIVAN) Last given 22Jun2022 7:44 AM, bupivacaine liposome (EXPAREL) Last given 22Jun2022 7:59 AM, ropivacaine (NAROPIN) Last given 22Jun2022 7:59 AM, dexAMETHasone (DECADRON) Last given 22Jun2022 8:17 AM, fentaNYL (SUBLIMAZE) Last given 22Jun2022 9:10 AM, diphenhydrAMINE (BENADRYL) Last given 22Jun2022 9:18 AM, indigo carmine Last given 22Jun2022 10:14 AM, rocuronium Last given 22Jun2022 11:27 AM, ondansetron (ZOFRAN) Last given 22Jun2022 12:04 PM, ePHEDrine Last given 22Jun2022 12:09 PM, sugammadex (BRIDION) Last given 22Jun2022 12:16 PM, ertapenem (INVanz) injection (time not given), Current Facility-Administered Medications During ER visit 26Jun2022 for Afib: sodium chloride 0.9 % flush bag 25mL Intravenous PRN, Sodium Chloride (PF) 0.9 % injection 2 mL Intracatheter 2 times per day, last Admin: 2Ml at 26Jun2022 0957, Sodium Chloride (NORMAL SALINE) 0.9 % bolus 500mL Intravenous once, diltiazem 5mg Intravenous once. Report stopping in Sep2022. Just didn't quite get it finalized to send to Moderna at that time. I waited to send it in until / had done the September probiotic challenge to get more confidence that the introduction of new probiotics was the likely cause of the rashes. Given the antibiotic exposure in March and especially June, prior to and during surgery, and given the stress of surgery itself, it is not unreasonable to assume that my gut was stressed. The introduction of new probiotics seems to have been the triggers 4 times for the 4 rounds of rash. It would be interesting to know if there has been an uptick of Afib following non-cardiac surgery since the COVID vaccines have been available but doubt it. It would be interesting to know if there has been an uptick of Afib following non-cardiac surgery since the COVID vaccines have been available but doubt it.  No follow-up attempts are possible. No further information is expected.